You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

CLINICAL TRIALS PROFILE FOR LIVALO

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for LIVALO

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00344370 ↗	Follow-On Study of Pitavastatin Versus Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia	Completed	Kowa Research Europe	Phase 3	2006-08-01	This is a sixteen-week double-blind active-controlled follow-on and 28-week single-blind extension study for patients who participated in study NK-104-305.
NCT00846118 ↗	Differential Intervention Trial by Standard Therapy Versus Pitavastatin in Patients With Chronic Hemodialysis (DIALYSIS)	Terminated	Chieko Hamada	N/A	2009-02-01	The purpose of this study is to verify whether pitavastatin prevents from cardiovascular events and improves the mortality in chronic hemodialysis patients with hypercholesteremia.
NCT00889226 ↗	Efficacy and Safety Study of Pitavastatin Compared to atoRvastatin in Type 2 dIabeTes Mellitus With Hypercholesterolemia	Completed	JW Pharmaceutical	Phase 4	2008-04-01	A randomized, open label, dose titration study to evaluate the efficacy and safety of Pitavastatin compared to atorvastatin in Type 2 Diabetes Mellitus with hypercholesterolemia
NCT01057433 ↗	Drug-Drug Interaction of Lopinavir/Ritonavir on Pitavastatin	Completed	Kowa Research Institute, Inc.	Phase 4	2010-01-01	This is a Phase 4, single center, open label, fixed-sequence, 2-way drug-drug interaction study.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for LIVALO

Condition Name

Chart
Table

Condition Name for LIVALO
Intervention	Trials
Hyperlipidemia	6
Dyslipidemia	6
Hypertension	3
Healthy Male Volunteers	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for LIVALO
Intervention	Trials
Hyperlipidemias	9
Hyperlipoproteinemias	7
Dyslipidemias	7
Hypercholesterolemia	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for LIVALO

Trials by Country

Map
Table

Trials by Country for LIVALO
Location	Trials
United States	106
Korea, Republic of	6
Canada	1
Denmark	1
Netherlands	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for LIVALO
Location	Trials
Texas	7
New York	5
Massachusetts	5
Florida	4
California	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for LIVALO

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for LIVALO
Clinical Trial Phase	Trials
Phase 4	11
Phase 3	5
Phase 1	5
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for LIVALO
Clinical Trial Phase	Trials
Completed	17
Withdrawn	2
Recruiting	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for LIVALO

Sponsor Name

Chart
Table

Sponsor Name for LIVALO
Sponsor	Trials
JW Pharmaceutical	6
Kowa Research Institute, Inc.	6
Kowa Pharmaceuticals America, Inc.	3
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for LIVALO
Sponsor	Trials
Other	38
Industry	22
NIH	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.